• Retrospective mortality and baseline health survey in Kutupalong and Balukhali settlement camps, Bangladesh

      Siddiqui, Ruby; White, Kate; Guzek, John; MSF-OCA (2018-07)
      2.1. PRIMARY OBJECTIVES To estimate the scale of the emergency through measurement of crude mortality rate for the total population and for children under five years of age 2.2. SECONDARY OBJECTIVES  To describe the population in terms of age, sex and household composition;  To determine the coverage of measles, polio, MenACWY, DPT-Hib-HepB (Pentavalent), cholera (OCV) and pneumococcal virus (PCV) vaccination in 6-59 month olds;  To determine the rate of severe and global acute malnutrition in 6-59 month olds;  To identify the most prevalent morbidities in the population in the two weeks preceding the survey;  To describe the health seeking behaviour in terms of access to primary and secondary care;  To estimate crude mortality rate for the total population and for children under five years of age before and after the SPLA advance into Equatoria, South Sudan;  To identify major causes of death, by age group and sex;  To gain knowledge of violence-related events 2.1. PRIMARY OBJECTIVES To estimate the scale of the emergency through measurement of crude mortality rate for the total population and for children under five years of age 2.2. SECONDARY OBJECTIVES  To describe the population in terms of age, sex and household composition;  To determine the coverage of measles, polio, MenACWY, DPT-Hib-HepB (Pentavalent), cholera (OCV) and pneumococcal virus (PCV) vaccination in 6-59 month olds;  To determine the rate of severe and global acute malnutrition in 6-59 month olds;  To identify the most prevalent morbidities in the population in the two weeks preceding the survey;  To describe the health seeking behaviour in terms of access to primary and secondary care;  To estimate crude mortality rate for the total population and for children under five years of age before and after the SPLA advance into Equatoria, South Sudan;  To identify major causes of death, by age group and sex;  To gain knowledge of violence-related events
    • Retrospective mortality and baseline health survey in Ofua village, Rhino settlement camp, Uganda

      Siddiqui, M Ruby; Cramond, Vanessa; Barre, Ibrahim; Johnson, Derek; MSF-OCA (2018-07)
      OBJECTIVES 2.1. PRIMARY OBJECTIVES To estimate the scale of the emergency through measurement of crude mortality rate for the total population and for children under five years of age 2.2. SECONDARY OBJECTIVES  To estimate the size of the population in Rhino (Ofua) settlement camp  To describe the population in terms of age, sex and household composition;  To determine the coverage of measles, polio, MenAfriVac, DPT-Hib-HepB (Pentavalent) and pneumococcal virus (PCV) vaccination in 6-59 month olds;  To determine the rate of severe and global acute malnutrition in 6-59 month olds;  To identify the most prevalent morbidities in the population in the two weeks preceding the survey;  To describe the health seeking behaviour in terms of access to primary and secondary care;  To estimate crude mortality rate for the total population and for children under five years of age before and after the SPLA advance into Equatoria, South Sudan;  To identify major causes of death, by age group and sex;  To gain knowledge of violence-related events  To determine the coverage of Long-Lasting Insecticide Treated bedNets (LLITNs)
    • Retrospective mortality and baseline health survey in Palorinya settlement camp, Uganda

      Siddiqui, M Ruby; Cramond, Vanessa; Goldberg, Jacob; Guzek, John; MSF-OCA (2018-07)
      2. OBJECTIVES 2.1. PRIMARY OBJECTIVES To estimate the scale of the emergency through measurement of crude mortality rate for the total population and for children under five years of age 2.2. SECONDARY OBJECTIVES  To estimate the size of the population in Palorinya settlement camp  To describe the population in terms of age, sex and household composition;  To determine the coverage of measles, polio, MenAfriVac, DPT-Hib-HepB (Pentavalent) and pneumococcal virus (PCV) vaccination in 6-59 month olds;  To determine the rate of severe and global acute malnutrition in 6-59 month olds;  To identify the most prevalent morbidities in the population in the two weeks preceding the survey;  To describe the health seeking behaviour in terms of access to primary and secondary care;  To estimate crude mortality rate for the total population and for children under five years of age before and after the SPLA advance into Equatoria, South Sudan;  To identify major causes of death, by age group and sex;  To gain knowledge of violence-related events  To determine the coverage of Long-Lasting Insecticide Treated bedNets (LLITNs)
    • Retrospective mortality survey in the MSF catchment area in Fizi health zone, South Kivu, Democratic Republic of Congo

      Lenglet, Annick; Bil, Karla; Mandelkow, Jantina; MSF-OCA (2018-07-31)
      . OBJECTIVES 2.1. PRIMARY OBJECTIVES To estimate the crude mortality rate for the total population (host and IDP) and for children under five years of age in the health zone of Fizi, South Kivu, DRC, in order to understand the current health status of the population in this catchment area. 2.2. SECONDARY OBJECTIVES  To determine the prevalence of self-reported morbidities in the two weeks preceding the survey in household members;  To determine the frequency and reasons for displacement;  To assess access to health care;  To determine the main causes of deaths during the recall period;  To measure the incidence and types of direct violence experienced by the civilian population;  To evaluate household ownership of basic non-food items;
    • Retrospective mortality survey in the MSF catchment area in Mayendit county, Unity State, South Sudan

      Pijnacker, Roan; Siddiqui, M Ruby; Rolfes, Elisabeth; Liddle, Karin Fisscher; Dada, Martins; Majok, Chap; MSF-OCA (2018-07)
      OBJECTIVES 2.1. PRIMARY OBJECTIVES  To estimate retrospectively the crude mortality rate for the total population and for children under five years of age in the MSF catchment area 2.2. SECONDARY OBJECTIVES  To describe the population surveyed by sex and age  To measure crude mortality rate for the total population and for children under five years of age  To obtain an indication of the major causes of death, as well as the age and sex distribution of the deceased  To determine the rate of severe and global acute malnutrition in 6-59 month olds;  To identify the most prevalent morbidities in the population in the two weeks preceding the survey;  To gain knowledge of violence-related events
    • Retrospective population-based mortality survey in an urban and rural area of Sierra Leone, 2015

      Caleo, Grazia; Kardamanidis, Katina; Broeder, Rob; Belava, Jaroslava; Kremer, Ronald; Lokuge, Kamalini; Greig, Jane; Turay; Saffa, Gbessay; MSF-OCA (2018-07)
      2. Objectives 2.1. Primary objectives The Primary objective of the survey is to:  Estimate mortality in a sample of the population in the urban and rural area of Bo District from the approximate start of the Ebola outbreak in Sierra Leone (mid May 2014) until the day of the survey. 2.2. Secondary objectives  Estimate overall and cause-specific mortality (EVD and non-EVD) in children under the age of 5 years, and the population aged 5 years and older within the study area, with particular attention to the period prior to the MSF Ebola Management Centre (EMC) opening in Bo district (19 September 2014) and the period during which it was receiving cases from the district (last confirmed case exited 26 January 2015);  Estimate overall and cause-specific mortality (EVD and non-EVD) in quarantined and non-quarantined households; and contact-traced and non-contact-traced households;  Describe health seeking behaviour in terms of whether health care was sought, where health care was sought and whether access to health care was possible.
    • Review of maternal mortality cases in MSF-OCA projects 2015 (a capture-recapture study)

      Price, Debbie; Lenglet, Annick; Thoulass, Janine; Willrich, Niklas; MSF-OCA (2018-07)
      Aim To identify the best method to monitor maternal mortality in MSF-OCA facilities prospectively. Objectives/Research questions  Evaluate the current surveillance system for maternal mortality in MSF-OCA facilities  Estimate maternal mortality in MSF-OCA facilities for 2015  Identify contributing factors to maternal mortality in MSF-OCA facilities for 2015
    • Review of MSF-OCA surveillance and alert response in Freetown during the Ebola outbreak: lessons learned and challenges

      West, Kim; Greig, Jane; Lokuge, Kamalini; Caleo, Grazia; Stringer, Beverley; Korr, Gerit Solveig; MSF-OCA (2018-07)
      Aim: To reduce suffering, morbidity and mortality by containing and reducing the spread of Ebola Virus Disease (EVD), while preserving human dignity for the affected population in Sierra Leone. Purpose: To reduce and ultimately eliminate the transmission of EVD in a defined catchment population in Freetown. Objectives: • Provide epidemiological technical support to intensify surveillance, supervision of the alert response and enhanced case investigation in the defined area. • Assess and respond to current gaps in infection prevention and control, water and sanitation, and triage in health facilities within the defined area. • Assess community social mobilisation, health promotion, contact tracing and quarantine interventions in the defined area and respond to any gaps through advocacy towards the relevant pillar/organization and/or through direct MSF intervention. • Prioritise MSF and health staff safety & biosecurity at all times • Medical (non-Ebola) and humanitarian needs of the population are monitored, recorded, analysed and responded to through advocacy or MSF action.
    • Risk factors for diagnosed Noma in North West Nigeria, 2017

      Lenglet, Annick; Farley, Elise; Trienekens, Suzan; Amirtharajah, Mohana; Bil, Karla; van der Kam, Saskia; Jiya, Nma M.; Huisman, Geke; Adetunji, Adeniyi Semiyu; Stringer, Beverley; et al. (2018-07)
      Background Noma is an orofacial gangrene that rapidly eats away at the hard and soft tissue as well as the bones in the face. Noma has a 90% mortality rate, and the disease affects mostly children under the age of 5. Little is known about Noma as the majority of cases live in underserved, difficult to reach locations. MSF runs projects at the Noma Children’s Hospital in Sokoto, northern Nigeria and currently assists with surgical interventions for the patients who have survived and sought care at the hospital. Community outreach and active case finding are also taking place. These projects place MSF in a unique position to study Noma, and to add to the scant body of knowledge around the disease. Aims and objectives Aim To identify risk factors for Noma in north west Nigeria in terms of epidemiological (demographic characteristics, medical history), socio-economic-behavioural aspects and access to health care in order to better guide existing prevention strategies. Specific objectives 1. To understand concepts and perceptions of Noma within the population of northwestern Nigeria, specifically those affected (caretakers of Noma cases) by the disease, and controls matching these cases. To describe the epidemiological profile of all cases of Noma that have been treated at the MSF Noma Children’s Hospital from August 2015 until June 2016; 2. To describe the current Noma patient’s clinical history before the onset of the disease, the start of the disease and the care/treatment sought as well as the impact of Noma on the patient; 3. To assess Noma risk factors by comparing cases enrolled at the Noma Children’s Hospital and controls matched to cases by sex, age, and village of residence; All of these objectives are in order to assess if there are intervention opportunities in the unique Nigerian setting that could prevent further Noma case development. Methods 1) Qualitative phase: focus groups will take place with care takers (guardians or parents) of cases as well as key informant interviews with health care workers to better understand the local concepts, vocabulary and expressions used to describe Noma in this part of Nigeria. 2) Descriptive epidemiology: description of all available medical, nutritional and mental health data associated with the Noma patients operated on at the Noma Children’s Hospital over the last year. 3) Case control study: assessing risk factors for Noma using care takers of cases recruited from the Noma Children’s Hospital and care takers of controls that are recruited from cases village of residence and matched by age and sex. Outcomes • Initiate the MSF operational research agenda around Noma in Nigeria; • Improved understanding of local beliefs, traditions and language used to describe Noma; • Improved understanding of Noma patients at the Sokoto Children’s hospital; • Identification of preventable risk factors for Noma development in our patients; • Integration of information obtained into outreach programming, improved community engagements, options for preventative campaigns and overall improved clinical and mental health care of Noma patients and caretakers in the MSF project.  
    • Secondary prophylaxis of visceral leishmaniasis relapses in HIV co-infected patients using pentamidine as a prophylactic agent: a prospective cohort study

      Diro, Ermias; Griensven, Johan van; Woldegebreal, Teklu; Belew, Zewdu; Taye, Melese; Yifru, Sisay; Davidson, Robert N.; Balasegaram, Manica; Lynen, Lut; Boelaert, Marleen; et al. (2018-07)
      2.1 OBJECTIVES 2.1.1 General objective: To document the effectiveness, safety and feasibility of monthly PM secondary prophylaxis (PSP) in VL/HIV co-infected patients that have documented parasite clearance after VL treatment when used for prevention of VL relapse. 2.1.2 Specific objectives of the primary study period 2.1.2.1 Primary objectives In VL/HIV co-infected patients that have documented parasite clearance after VL treatment: - to assess the effectiveness of PSP in terms of preventing relapse and death; - to assess the safety of PSP in terms of drug-related serious adverse events or permanent drug discontinuations due to adverse events; - to assess the feasibility of PSP in terms of number of patients compliant to therapy during the first year of monthly PM secondary prophylaxis. 2.1.2.2 Secondary objectives; In VL/HIV co-infected patients that have documented parasite clearance after VL treatment: - to assess the safety of PSP in terms of: - drug-related non-serious adverse events - serious adverse events (drug-related or not) - to assess the feasibility of PSP in terms of: - number of treatment interruptions/discontinuations, - number of therapeutic interventions needed to treat adverse drug reactions
    • Severe acute malnutrition and retrospective all-cause mortality in children under 5 years of age in target areas of Zamfara State, Nigeria: a SMART survey.

      Hadera, Amdom; Huisman, Geke; Kaur, Gurpreet; Oluyide, Bukola; Greig, Jane E.; Bil, Karla; Roggeveen, Harriet; van der Kam, Saskia; MSF-OCA (2018-07)
      2. OBJECTIVES 2.1. PRIMARY OBJECTIVES To estimate the all-cause mortality rate and proportion of SAM in children under 5 years of age in target areas in Zamfara State. 2.2. SECONDARY OBJECTIVES  To determine causes of death  To assess morbidity  To assess health seeking behaviour  To assess food security and nutritional practices  Estimate the prevalence of gingivitis in children <5 years of age
    • Study Concept Paper Template

      MSF (2017-08-21)
      This is a simple template to highlight the issues to be addressed when developing a research question.
    • SURVEY OF PLASMODIUM FALCIPARUM SULFADOXINE/PYRIMETHAMINE (SP) RESISTANCE MARKERS IN MSF PROJECTS IN NORTH AND SOUTH KIVU, DR CONGO Short Title: SP Resistance Molecular Marker Prevalence Survey DRC

      de Wit, Marit; Rao, Bhargavi; Lassovski, Maryvonne; Ouabo, Adelaide; Badjo, Colette; Bousema, Teun; Roper, Cally; Okell, Lucy; Piriou, Erwan; Cibinda; et al. (2018-07)
      Primary Objective: To measure the prevalence of molecular markers of SP resistant malaria in North and South Kivu, DRC. Sulfadoxine/pyrimethamine (SP) forms the backbone of most malaria chemoprevention programmes in high endemicity settings, including intermittent preventative therapy in pregnancy and infants (IPTp and IPTi respectively) as well as seasonal malaria chemoprevention (SMC). P. falciparum parasite resistance to SP threatens recent triumphs preventing malaria infection in the most vulnerable risk groups. WHO guidance is that chemoprevention using SP may not be implemented when prevalence of the dhps K540E gene denoting SP resistance are greater than 50%. Simple, robust polymerase chain reaction (PCR) - based methods for molecular surveillance of resistance to SP have the potential to indicate whether SP-based chemoprevention programmes would be effective in areas where surveillance was conducted, but also to identify early stages of emerging resistance in order to advocate for alternative chemoprevention strategies.A minimum of 750 samples will be collected per province. Three sites per province will provide 250 samples assuming an estimated prevalence of 50% prevalence of dhps K540E gene with 95% confidence and 5% precision. This is also sufficient for robust estimation of the prevalence of dhps 581, an alternative critical marker. This sample size is calculated to estimate regional prevalence, i.e. for both South Kivu and North Kivu, and hence this study requires samples from multiple MSF sites (including from different MSF Operating Centre missions) e.g. Baraka, Kimbi and Lulingu amongst others in South Kivu and Mweso, Rutsuru and Walikale in North Kivu with a minimum total of 750 per province. If estimating specific prevalence in only one limited site, a large sample size would be required.
    • Understanding the health status and humanitarian impact of the recent events in the internally displaced population (IDPs) in Tal Abyad and Manbij districts, northern Syria, 2017

      Malaeb, Rami; Lenglet, Annick; Langlois, Celine; White, Kate; Hussein, Shajib; de Boever, Rieneke; Onus, Robert; Desoulieres, Sophie; MSF-OCA (2018-07)
      Aims and objectives 2.1. Primary objective To estimate the prevalence of current illnesses (self-reported), vaccination coverage, and mental health distress related symptoms in the IDP population in order to obtain a baseline that can guide MSF response activities in Raqqa as well as in Tal Abyad and Manbij districts. 2.2. Secondary objectives 1) To estimate the vaccination coverage for key vaccine preventable diseases in children aged 6-59 months among the new IDP population; 2) To describe the demographic characteristics of the IDP population; 3) To describe the displacement routes and experiences of the IDP population; 4) To estimate the prevalence of self-reported morbidities in the previous two weeks; 5) To estimate the global acute malnutrition (GAM) rate of in children aged 6-59 months and pregnant women; 6) To estimate the prevalence of self-reported major chronic diseases; 7) To estimate the prevalence of symptoms commonly associated with mental health distress; 8) To estimate the prevalence of conflict-related violence/trauma experienced during the recall period (365 days); 9) To estimate the retrospective mortality since the beginning of Ar-Raqqa offensive in northern Syria (12 June 2016); 10) To gain more understanding related to the concerns, challenges and priority needs of the IDPs in the community.